Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Event Types
- WCBP (461)
- Cell & Gene Therapy Products (230)
- CMC Strategy Forum Europe (196)
- CE Pharm (187)
- Mass Spectrometry (173)
- Bioassays (134)
- Higher Order Structure (109)
- AT Europe (109)
- CMC Strategy Forum Japan (105)
- CMC Strategy Forum (78)
- CMC Strategy Forum North America Winter (77)
- CMC Strategy Forum North America Summer (61)
- CMC Strategy Forum Latin America (40)
- CGTP Summit (37)
- CMC Strategy Forum China (29)
- Consultants' Network (15)
- CMC Strategy Forum North America Fall (14)
- CGTP Europe (11)
- Symposium on mRNA (11)
- Virtual Summit: Bioconjugates (9)
- Virtual Summit: Manufacturing (8)
- Biophysics Working Group (8)
- Virtual Europe Discussion Group (8)
- CGTP Virtual Summit (7)
- NorCal Regional Forum (6)
- Netherlands Area Biotech Discussion Group (5)
- DC Area Scientific Discussion Group (4)
- Biotech Working Group (2)
- Midwest Regional Forum (2)
- CMC-Vaccines Working Group (1)
Filter By Tags
-
Manufacturing Changes and Comparability for Cell and Gene Therapy Products
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/cgtp/2023/cgtp2023_120x120_landing.jpg?sfvrsn=68c815da_3)
Speaker Presentation: CGTP 2026 Timmons Andrew, CBER, FDA, 2026 -
Plasmid-Free mRNA Synthesis on a Reusable Solid-Phase IVT Platform
Speaker Presentation: CGTP 2026 Teo Catherine, Avantor, Inc., 2026
-
Navigating the “DS vs. Critical Component” Continuum for Gene Editing Tools: Lessons from Autologous Cell Therapy Program Lifecycle Management
Speaker Presentation: CGTP 2026 Som Leakhena, AstraZeneca, 2026
-
CMC Considerations for CRISPR and Next-Gen Technologies, Including ElevateBio's LETI-101 as a Case Study
Speaker Presentation: CGTP 2026 Sena April, ElevateBio, 2026
-
Holistic Thinking for PPQ Strategy: Lessons Learned and Future Opportunities
Speaker Presentation: CGTP 2026 Rodley Mary, Medius Consulting, LLC, 2026
-
A Quantitative Nuclear Translocation Assay for the Functional Characterization of Recombinant AAV
Speaker Presentation: CGTP 2026 Pathak Prerana, Biogen, 2026
-
Advancing Global Submissions Through a One Dossier Operating Model: Concept, Implementation and Early Outcomes
Speaker Presentation: CGTP 2026 Pappas Jen, AstraZeneca, 2026
-
Facilitating the Transition to Late-Stage Gene Therapy Manufacturing
Speaker Presentation: CGTP 2026 Levendosky Robert, Catalent, 2026
-
Considerations for Leveraging Prior Knowledge for Cell and Gene Therapy Products
Speaker Presentation: CGTP 2026 Lee Stella, CBER, FDA, 2026
-
Adventures in Making Extreme mRNA Molecules
Speaker Presentation: CGTP 2026 Larsen Aaron, Crystal NAX Inc., 2026
-
Current Status of Regenerative Medical Products in Japan
Speaker Presentation: CGTP 2026 Kishioka Yasuhiro, PMDA -Pharmaceuticals and Medical Devices Agency, …
-
Manufacturing of mRNA by Fed-Batch in Vitro Transcription: Optimization of Production Costs, Space-Time Yield, and Product Quality
Speaker Presentation: CGTP 2026 Guo May, Biomay AG, 2026
-
Developing First-in-Class In Vivo Epigenome Editing for Chronic Hepatitis B: Accelerated CMC Development Strategies
Speaker Presentation: CGTP 2026 Goodwin Tyler, Tune Therapeutics, 2026
-
Driving Concurrent US and EU Approvals for Gene Therapies Using a Reg-CMC Roadmap
Speaker Presentation: CGTP 2026 Gangurde Rajiv, Parexel International, 2026
-
Recommendations With Regard To Future ATMP Related Guidelines Output From Cell & Gene Therapy Discussion Group (CGTDG)
Speaker Presentation: CGTP 2026 Francissen Kathleen, Genentech, a Member of the Roche Group, 2026
-
Cell & Gene Therapy Discussion Group(CGTDG)
Speaker Presentation: CGTP 2026 Francissen Kathleen, Genentech, a Member of the Roche Group, 2026
-
Designing a Modular CMC Platform for Lentiviral Gene Therapies
Speaker Presentation: CGTP 2026 Castellaro Diego, Fondazione Telethon ETS, 2026
-
PPQ Under Pressure: Designing Practical Validation Strategies for CGT Programs
Speaker Presentation: CGTP 2026 Cardenas Javier, Eliquent Life Sciences, 2026
-
Development of an Off-Target Strategy for a Novel Small Nuclease
Speaker Presentation: CGTP 2026 Bobbin Maggie, Mammoth Biosciences, Inc., 2026
-
PPQ-As-You-Go: Accumulating CMC Validation Evidence in Step with Clinical Data in Rare Genetic Disease Programs
Speaker Presentation: CGTP 2026 Bell Chris, Prime Medicine, Inc., 2026